` COO (Corum Group Ltd) vs S&P/ASX 300 Comparison - Alpha Spread

COO
vs
S
S&P/ASX 300

Over the past 12 months, COO has underperformed S&P/ASX 300, delivering a return of 0% compared to the S&P/ASX 300's +15% growth.

Stocks Performance
COO vs S&P/ASX 300

Loading
COO
S&P/ASX 300
Add Stock
www.alphaspread.com
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Performance Gap
COO vs S&P/ASX 300

Performance Gap Between COO and AXKO
LOCKED
Unlock

Performance By Year
COO vs S&P/ASX 300

Loading
COO
S&P/ASX 300
Add Stock
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Competitors Performance
Corum Group Ltd vs Peers

No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Corum Group Ltd
Glance View

Market Cap
25.7m AUD
Industry
Technology

Corum Group Ltd. engages in the research and development of software solutions. The company is headquartered in Sydney, New South Wales. The firm is focused on developing point-of-sale, dispensing and management software for pharmacy head offices and retail stores and a range of e-commerce and ordering solutions throughout Australia. The firm operates through Corum Health segment. The Corum Health segment develops and distributes business software for the pharmacy industry with emphasis on point-of-sale and pharmaceutical dispensing software, multi-site retail management, support services and computer hardware. Corum Health also includes PharmX, an electronic gateway that links pharmacies, pharmaceutical wholesalers, and direct suppliers within the pharmacy market.

COO Intrinsic Value
Not Available
Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett